Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EMvision Medical Devices.
RELATED STOCKHEAD STORIES
Health & Biotech
Another 2 ASX health stocks confirm they’ve received a major government grant
News
10 at 10: It’s a new spring for these ASX stocks this morning
Experts
MoneyTalks: Could this ASX medtech stock become the next Cochlear?
Health & Biotech
Micro-X gains after portable X-ray company wins $8m stroke grant
Experts
ScoPo’s health powerplays: ‘We said October was going to be volatile’
Director Trades
Directors’ Trades: It is ever too late to jump on the bandwagon?
IPO Watch
2018 ASX IPOs are doing much better two years on
Health & Biotech
Factor Therapeutics may finally have found its future — in veterinary imaging
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Dr Boreham’s Crucible: Will EMVision’s links to Nanosonics set it up for similar success?
Health & Biotech
Medtech needs more than a TGA tick to hit the big $$$
Health & Biotech
Are we mortgaging the future as COVID-19 closes clinical trials?
Health & Biotech
Noxopharm wants to test its anti-prostate cancer drug against COVID-19
Health & Biotech
Cann pulls back from Mildura pot project as world flooded with weed
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
